Swiss Startup Framework: A Highly Effective Network Supporting the Generation of Emerging Biotech Businesses

CHIMIA

Stefan Steiner¹  Isabelle Mitchell¹  Michael Altorfer¹  Laura Suter-Dick¹ 

[1] Swiss Biotech Association, swissbiotech.org;

关键词: biotechnology;    financing;    innovation;    startups;    therapeutics;   

DOI  :  10.2533/chimia.2020.765

来源: DOAJ

【 摘 要 】

For over 50 years, Switzerland has been one of the leading countries driving innovation in biotechnology and its industrial applications. Today, some 1,000 biotech companies form a tightly knit, cross-functional network ranging from research through to manufacturing. This network comprises R&D companies, contract research organizations, and highly specialized advisors and biotech investors. Together, they form an external innovation pool that complements the in-house R&D capacity of the large multi-national pharma companies. A highly effective startup framework, solid acceleration mechanisms, and innovative investors enable the emergence of a continuous flow of biotech startups that revitalize the industry with new technologies and products supporting drug development and diagnostics.

【 授权许可】

Unknown